Crown use licensing: a loaded threat for pharma?

The battle between NHS England and American pharmaceutical company Vertex over the cost of the revolutionary cystic fibrosis drug, Orkambi, rages on. In the latest development, campaign groups are upping the ante, backed in Parliament...Read more